Arcturus therapeutics posts q2 loss per share of $0.55

Arcturus therapeutics announces second quarter 2020 financial results and provides a corporate update.q2 revenue $2.3 million versus $10.2 million.q2 loss per share $0.55.q2 revenue estimate $3.5 million -- refinitiv ibes data.q2 earnings per share estimate $-0.55 -- refinitiv ibes data.

ARCT Ratings Summary

ARCT Quant Ranking